IRLAB's Drug Candidates IRL942 and IRL1009 Have Been Granted Patents in the US and Europe PR Newswire STOCKHOLM, Nov. 6, 2019 STOCKHOLM, Nov. 6, 2019 /PRNewswire/ -- IRLAB announced today that...
IRLAB's Drug Candidates IRL942 and IRL1009 Have Been Granted Patents in the US and Europe PR Newswire STOCKHOLM, Nov. 6, 2019 STOCKHOLM, Nov. 6, 2019 /PRNewswire/ -- IRLAB announced today that...
IRLAB Presents at the 2019 International Congress of Parkinson's Disease and Movement Disorders PR Newswire STOCKHOLM, Sept. 23, 2019 STOCKHOLM, Sept. 23, 2019 /PRNewswire/ -- IRLAB announced...
IRLAB Presents at the 2019 International Congress of Parkinson's Disease and Movement Disorders PR Newswire STOCKHOLM, Sept. 23, 2019 STOCKHOLM, Sept. 23, 2019 /PRNewswire/ -- IRLAB announced...
IRLAB to Advance Clinical Development of IRL790 in LIDs Based on In-depth Analysis of Positive Phase IIa Results PR Newswire STOCKHOLM, Aug. 28, 2019 STOCKHOLM, Aug. 28, 2019 /PRNewswire/...
IRLAB to Advance Clinical Development of IRL790 in LIDs Based on In-depth Analysis of Positive Phase IIa Results PR Newswire STOCKHOLM, Aug. 28, 2019 STOCKHOLM, Aug. 28, 2019 /PRNewswire/...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관